f-ESWT vs Steroid Injection for Piriformis Syndrome

Gulhane Training and Research Hospital

Status: Not yet enrolling

Conditions: Piriformis Syndrome

Treatments: Other: Focal extracorporeal schock wave therapy; Procedure: Steroid Injection

Study type: Observational

Funder types: Other

Identifiers

NCT07145554

GulhaneTRH

Details and patient eligibility

About

This study aims to compare two treatment methods for piriformis syndrome, a condition that can cause pain in the buttock and leg. Adult patients with piriformis syndrome will take part in the trial. Participants will be randomly assigned to one of two groups. One group will receive focal extracorporeal shock wave therapy (f-ESWT), a non-invasive treatment that uses sound waves. The other group will receive a steroid injection, which is a common treatment used to reduce pain and inflammation. The goal of this study is to find out which treatment is more effective in improving symptoms of piriformis syndrome.

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with piriformis syndrome whose pain has persisted for three months or longer despite standard medical care and activity modifications.

Exclusion criteria

• Individuals with lumbar discopathy diagnosed by magnetic resonance imaging or electrodiagnostic study.
• Patients with coccyx pain.
• Individuals with mechanical or inflammatory disorders of the sacroiliac joint.
• Patients with pelvic region diseases.
• Pregnancy
• History of previous lumbar disc surgery.
• History of lumbar epidural block within the last 6 months.
• History of malignancy.
• Patients with signs of acute inflammation at the treatment site.
• Individuals with a cardiac pacemaker.

Trial design

40 participants in 2 patient groups

Shock wave group

Treatment:

Other: Focal extracorporeal schock wave therapy

Injection group

Treatment:

Procedure: Steroid Injection